Robert I. Blum - May 31, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John Faurescu, attorney-in-fact for Mr. Blum
Stock symbol
CYTK
Transactions as of
May 31, 2023
Transactions value $
-$350,250
Form type
4
Date filed
6/1/2023, 05:06 PM
Previous filing
May 16, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $121K +12.5K +2.83% $9.65 454K May 31, 2023 Direct F3
transaction CYTK Common Stock Sale -$471K -12.5K -2.76% $37.67 441K May 31, 2023 Direct F3
holding CYTK Common Stock 2.08K May 31, 2023 by Trust 1 F1
holding CYTK Common Stock 2.08K May 31, 2023 by Trust 2 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -12.5K -17.68% $0.00 58.2K May 31, 2023 Common Stock 12.5K $9.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares held by The Bridget Blum 2003 Irrevocable Trust.
F2 Shares held by The Brittany Blum 2003 Irrevocable Trust.
F3 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.